Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Adjunctive Alteplase During Primary PCI (T-TIME)
NCT02257294Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Mar 2016
- Primary completion
- Jul 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in myocardial infarction (MI), sponsored by NHS Greater Glasgow and Clyde. Started Mar 2016; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02257294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257294.